Bliss GVS Pharma

Anupam Rasayan completes acquisition of Bliss GVS Pharma

Anupam Rasayan finalized the acquisition of Bliss GVS Pharma for $182.3 million, securing a controlling stake and entering the finished dosage formulations segment. This strategic move expands their g